CN Patent

CN105412930A — 血小板生成素受体激动剂在促进造血干细胞归巢中的用途

Assigned to SOUTH CHINA CENTER FOR STEM CELL BIOLOGY AND REGENERATIVE MEDICINE OF ACADEMY OF MILITARY MEDICAL SCIENCES · Expires 2016-03-23 · 10y expired

What this patent protects

本发明公开了血小板生成素受体激动剂在促进造血干细胞归巢中的用途。其中，血小板生成素受体激动剂能够有效促进骨髓移植术后造血干细胞归巢，进而血小板生成素受体激动剂能够有效用于制备促进造血干细胞归巢的药物，该药物能够增加归巢的造血干细胞的数量，提高造血干细胞归巢效率，进而能够促进造血干细胞的植入，提高骨髓造血干细胞的移植成功率。

USPTO Abstract

本发明公开了血小板生成素受体激动剂在促进造血干细胞归巢中的用途。其中，血小板生成素受体激动剂能够有效促进骨髓移植术后造血干细胞归巢，进而血小板生成素受体激动剂能够有效用于制备促进造血干细胞归巢的药物，该药物能够增加归巢的造血干细胞的数量，提高造血干细胞归巢效率，进而能够促进造血干细胞的植入，提高骨髓造血干细胞的移植成功率。

Drugs covered by this patent

Patent Metadata

Patent number
CN105412930A
Jurisdiction
CN
Classification
—
Expires
2016-03-23
Drug substance claim
No
Drug product claim
No
Assignee
SOUTH CHINA CENTER FOR STEM CELL BIOLOGY AND REGENERATIVE MEDICINE OF ACADEMY OF MILITARY MEDICAL SCIENCES
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.